Author: Bella Hayes

Investing.com — Mercedes-Benz (OTC:) faced a challenging year in 2024, with full-year sales falling slightly below 2023 levels amid global economic headwinds and shifting market dynamics.  The German automaker reported total sales of 2,389,000 cars and vans, despite reporting its strongest quarter of the year in Q4, during which it sold 625,800 vehicles. Mercedes-Benz Cars delivered 1,983,400 vehicles over the year, with quarter-on-quarter sales rising to 520,100 units in the final three months.  While this marked an improvement in markets like Germany, China, and the United States, the overall figures did not match the previous year’s performance.  The automaker’s high-end…

Investing.com — Vodafone Plc (LON:) on Friday said it had completed the sale of its remaining stake in Indus Towers (NS:), raising about 28 billion Indian rupees (US $330 million).  The transaction, conducted through an accelerated book build offering on December 5, 2024, involved the sale of 79.2 million shares, representing 3% of Indus Towers’ outstanding share capital. As per the telecom company’s statement, part of the proceeds—amounting to 8.9 billion rupees ($105 million)—was used to fully repay loans secured against its Indian assets.  This also covered associated transaction fees, allowing the company to close its obligations with existing lenders. The…

Investing.com — Shares of J Sainsbury PLC (LON:) fell over 2% on Friday after the retailer reported its third-quarter trading update.  Despite strong grocery sales during Christmas, weaker performance in non-grocery segments and margin pressures weighed on the stock. Like-for-like sales (excluding fuel) rose 2.8% in the 16 weeks to January 4, driven by a 4.1% increase in grocery sales.  Premium “Taste the Difference” products saw a 16% rise, and holiday-specific items performed strongly.  However, general merchandise, including Argos, saw a 1.4% decline, and clothing sales were flat. Argos sales during the eight weeks to Christmas rose 1.1%, but the…

LONDON – Logistics Development Group plc (LDG) and Aegros Bidco Limited (Bidco) have agreed on the acquisition terms for Alliance Pharma (LON:) plc, valuing the healthcare company at £337.9 million. The transaction is set to be executed through a court-sanctioned scheme of arrangement at a price of 62.5p per Alliance share. Alliance Pharma, a global healthcare firm based in Chippenham, Wiltshire, employs over 290 people and specializes in marketing and distributing over-the-counter consumer healthcare and prescription products. As of June 30, 2024, the company reported net assets of £222.9 million and an Adjusted EBITDA of £45.0 million on revenues of…

HANGZHOU, China, Jan. 10, 2025 /PRNewswire/ — BEST Inc. (NYSE: NYSE:) (“BEST” or the “Company”), a leading integrated smart supply chain solutions and logistics services provider in China and Southeast Asia, today announced that, on January 6, 2025, the Company received a notice from the New York Stock Exchange (the “NYSE”) Regulation stating that it is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria pursuant to Section 802.01E of the NYSE Listed Company Manual (the “Continued Listing Criteria”) as a result of the Company’s failure to timely file its Form 6-K containing semi-annual financial…

Investing.com– Bitcoin fell on Friday and was set for steep losses this week as heightened concerns over slower U.S. interest rate cuts and potential coin sales by the government eroded sentiment towards crypto. Crypto markets also largely tracked a downturn in broader risk-driven markets, as traders pivoted into safe havens such as gold and the amid heightened economic uncertainty. The world’s biggest cryptocurrency was also subject to profit-taking after tripling in value through 2024. Broader crypto prices also fell in tandem with Bitcoin. fell 0.6% to $93,925.0 by 00:56 ET (05:56 GMT). The coin had briefly fallen as low as…

Strategy anchored on early clinical development of proprietary assets with single-agent potential:Drive innovation with first-in-class ANKET ® NK-cell engager PlatformAccelerate development of differentiated Antibody-Drug ConjugatesAdvance current late-stage assets through partnerships MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (OTC:) ( Euronext (EPA:) Paris: IPH; : IPHA) (Innate or the Company) today announced its updated strategy for company growth. This comprehensive plan is anchored in three key pillars designed to drive sustainable growth, foster innovation, and deliver transformative therapies to patients worldwide. “Our updated strategy underscores Innate Pharma (EPA:)’s unwavering dedication to innovation, collaboration, and delivering transformative therapies for patients worldwide,” said…

By Suzanne McGee (Reuters) – What a difference a year makes. Rewind the clock to early January 2024, and the asset-management industry was anxiously watching to see if the much-anticipated debut of U.S. spot bitcoin exchange-traded funds could live up to expectations they would pull in as much as $30 billion in their first year. Today, those issuers are cracking open the champagne. That first wave of bitcoin ETFs attracted a whopping $65 billion in 2024, helping to propel the price of bitcoin from $43,000 to more than $100,000. The largest of those new products, BlackRock (NYSE:)’s iShares Trust, has…

New York, New York–(Newsfile Corp. – January 9, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company’s April 11, 2024 initial public offering (“IPO”); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the “Class Period”); and/or (iii) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s September 2024 secondary public offering (“SPO”), of the…

New York, New York–(Newsfile Corp. – January 9, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares, including those that purchased call options and/or sold put options, of ASML Holding N.V. (NASDAQ: AS:) between January 24, 2024 and October 15, 2024, both dates inclusive (the “Class Period”), of the important January 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased ASML ordinary shares and/or purchased call options and/or sold put options during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs…